Enteral Feeding of Premature Babies and Olive Oil Supplementation
- Conditions
- PrematureEnteral FeedingOlive Oil
- Registration Number
- NCT06072625
- Lead Sponsor
- Bursa City Hospital
- Brief Summary
It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml/kg/day of the study product (ULTRA PREMIUM) after full enteral feeding.
Supplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values.
Daily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 80
- Premature babies born at 32 weeks or less
- Babies who tolerate full enteral feeding at the before end of the second week
- Babies given consent by their parents -
- Having a congenital or genetic anomaly
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of patients who completed the study 15 months To enrolment of 40 babies in the study in both groups
Postnatal growth retardation rates 18 months Daily weight intake amounts of babies in both groups
- Secondary Outcome Measures
Name Time Method Frequency and severity of retinopathy of prematurity 18 months Frequency and severity of retinopathy of prematurity
Trial Locations
- Locations (1)
Bursa City Hospital
🇹🇷Bursa, Turkey
Bursa City Hospital🇹🇷Bursa, Turkey